Breaking news

Nvidia Unleashes Evo 2: The AI Powerhouse For Genetic Research

Nvidia, the U.S.-based AI chip giant, has unveiled Evo 2, the most advanced artificial intelligence system dedicated to biomolecular science. Built-in collaboration with Stanford University and the nonprofit Arc Institute, Evo 2 is set to redefine genetic research, accelerating breakthroughs in medicine and biotechnology.

AI Meets Genomics

Powered by Nvidia DGX Cloud on Amazon Web Services (AWS), Evo 2 is designed to decode the complexities of DNA, RNA, and proteins across a vast spectrum of species. With a dataset of nearly 9 trillion nucleotides—the fundamental units of DNA and RNA—this AI model is poised to revolutionize biological research. Its capabilities extend to predicting protein structures, identifying novel molecules for healthcare and industrial applications, and analyzing the effects of genetic mutations.

Evo 2 is now the largest publicly available AI model for genomic data, offering scientists an unprecedented tool for biological discovery. Researchers can leverage Nvidia’s NIM microservice to generate biological sequences and fine-tune the model using their proprietary datasets via the open-source Nvidia BioNeMo Framework.

Game-Changing Potential

“Evo 2 represents a major milestone for generative genomics,” said Patrick Hsu, cofounder of Arc Institute and assistant professor of bioengineering at UC Berkeley. “By deepening our understanding of life’s fundamental building blocks, we can unlock new possibilities in healthcare and environmental science that were once unimaginable.”

Brian Hie, assistant professor of chemical engineering at Stanford and faculty fellow at the Dieter Schwarz Foundation Stanford Data Science, echoed this sentiment: “With Evo 2, complex biological design becomes more accessible, allowing researchers to develop groundbreaking innovations in a fraction of the time.”

Market Reaction

Despite the breakthrough, Nvidia’s stock dipped 0.2% in after-hours trading on Wednesday, settling at $139 per share, with a market capitalization of $3.4 trillion. However, as AI-driven biotech advances continue to gain momentum, Nvidia’s role in shaping the future of medicine and genomics remains stronger than ever.

Bitcoin Surges 23% In A Week As Investor Optimism Returns

Bitcoin was on track for a weekly gain of around 23% on Friday as a series of positive macroeconomic and policy developments boosted investor sentiment.

The cryptocurrency was trading about 6% higher at roughly $77,000, up from around $62,800 at the start of the week. Crypto-related stocks also rallied, with Coinbase and Circle gaining more than 9%, while Strategy rose 7%.

Macro Factors Fuel Rally

Bitcoin’s latest surge began Wednesday after Treasury yields fell sharply following a major intervention by the U.S. Treasury in the bond market. Lower yields eased pressure on risk assets and helped trigger a broader move into cryptocurrencies.

The rally was further amplified by a major short squeeze. Around $2.7 billion in crypto short positions were liquidated, according to CoinGlass.

Max Stuedlein, head of Partnerships at Sygnum APAC, said the move reflected an alignment of macroeconomic and policy catalysts, including the Treasury’s decision to increase buybacks of longer-dated government debt.

Clarity Act Boosts Sentiment

Investor confidence improved further on Thursday as the White House and crypto industry leaders made a final push to advance the Clarity Act in the coming weeks.

The legislation is widely viewed as a potential catalyst for the crypto market, although its chances of passing remain relatively limited.

Despite the rally, bitcoin remains well below its 2026 high of $94,820 reached in January and its all-time high of $126,198, set last October.

Analysts See More Volatility Ahead

Lucy Gazmararian, founder and managing partner at Token Bay Capital, said the crypto market may be approaching the end of its bear cycle.

She expects bitcoin could experience one more decline of around 20% before the market turns, pointing to historical cycles and the recent liquidation of heavily leveraged short positions.

Gazmararian also described bitcoin as a long-term hedge against monetary debasement, while warning that its short-term price remains highly volatile and driven by market cycles.

Aretilaw firm
Uol
eCredo
The Future Forbes Realty Global Properties

Become a Speaker

Become a Speaker

Become a Partner

Subscribe for our weekly newsletter